Balance Sheet Information (GEN-PROBE INCORPORATED [Member])

12 Months Ended

Jun. 30, 2012

Dec. 31, 2011

GEN-PROBE INCORPORATED [Member]

Balance Sheet Information

Note 3. Balance Sheet Information

The following tables provide details of selected balance sheet line items as of June 30, 2012 and December 31, 2011 (in thousands):

Inventories

	June 30,		December 31,
	2012		2011
Raw materials and supplies	$	24,634	$	19,429
Work in process		29,341		27,464
Finished goods		36,914		30,993
Inventories	$	90,889	$	77,886

Property, Plant and Equipment, Net

	June 30,			December 31,
	2012			2011
Land	$	19,360		$	19,355
Building		78,317			80,005
Machinery and equipment		220,099			213,729
Building improvements		64,830			60,628
Furniture and fixtures		22,465			21,790
Construction in-progress		1,099			2,789
Property, plant and equipment, at cost		406,170			398,296
Less: accumulated depreciation and amortization		(228,563	)		(222,215	)
Property, plant and equipment, net	$	177,607		$	176,081

Purchased Intangibles

	June 30, 2012					December 31, 2011
	Gross		Accumulated Amortization			Gross		Accumulated Amortization
Customer relationships	$	76,765	$	(18,824	)	$	77,326	$	(15,723	)
Developed technology		60,706		(39,432	)		59,206		(38,292	)
Trademarks		10,551		(1,715	)		10,817		(1,487	)
Trade names		7,300		(618	)		7,300		(435	)
In-process research and development		6,407		—			7,907		—
Total purchased intangibles	$	161,729	$	(60,589	)	$	162,556	$	(55,937	)

License, Manufacturing Access Fees and Other Assets, Net

	June 30,			December 31,
	2012			2011
License and manufacturing access fees	$	68,889		$	67,906
Investment in Qualigen, Inc.		5,404			5,404
Investment in DiagnoCure, Inc.		5,000			5,000
Investment in Roka Bioscience, Inc.		4,705			4,705
Other assets		11,748			11,257
License, manufacturing access fees and other assets, at cost		95,746			94,272
Less: accumulated amortization		(35,995	)		(32,534	)
License, manufacturing access fees and other assets, net	$	59,751		$	61,738

Other Accrued Expenses

	June 30,		December 31,
	2012		2011
Research and development	$	4,578	$	3,554
Professional fees		3,902		1,148
Royalties		2,812		3,047
Marketing and sales		1,455		1,261
Other		3,229		3,836
Other accrued expenses	$	15,976	$	12,846

Note 6. Balance Sheet Information

The following tables provide details of selected balance sheet items (in thousands):

Inventories

	December 31, 2011		December 31, 2010
Raw materials and supplies	$	19,429	$	16,915
Work in process		27,464		21,446
Finished goods		30,993		28,055
Inventories	$	77,886	$	66,416

Property, Plant and Equipment

	December 31, 2011			December 31, 2010
Land	$	19,355		$	19,287
Building		80,005			80,010
Machinery and equipment		213,729			195,927
Building improvements		60,628			48,217
Furniture and fixtures		21,790			21,999
Construction in-progress		2,789			1,855
Property, plant and equipment, at cost		398,296			367,295
Less: accumulated depreciation and amortization		(222,215	)		(206,432	)
Property, plant and equipment, net	$	176,081		$	160,863

Other Accrued Expenses

	December 31, 2011		December 31, 2010
Royalties	$	3,047	$	3,978
Research and development		3,454		3,385
Professional fees		1,148		1,182
Marketing		1,261		1,177
Interest		200		233
Warranty		137		373
Other		3,599		3,607
Other accrued expenses	$	12,846	$	13,935